Pácha Jiří, Balounová Kateřina, Soták Matúš
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic.
Expert Opin Drug Metab Toxicol. 2021 Apr;17(4):425-439. doi: 10.1080/17425255.2021.1868438. Epub 2021 Jan 4.
: Solute Carrier (SLC) and ATP-binding cassette (ABC) transporters expressed in the intestine, liver, and kidney determine the absorption, distribution, and excretion of drugs. In addition, most molecular and cellular processes show circadian rhythmicity controlled by circadian clocks that leads to diurnal variations in the pharmacokinetics and pharmacodynamics of many drugs and affects their therapeutic efficacy and toxicity.: This review provides an overview of the current knowledge on the circadian rhythmicity of drug transporters and the molecular mechanisms of their circadian control. Evidence for coupling drug transporters to circadian oscillators and the plausible candidates conveying circadian clock signals to target drug transporters, particularly transcription factors operating as the output of clock genes, is discussed.: The circadian machinery has been demonstrated to interact with the uptake and efflux of various drug transporters. The evidence supports the concept that diurnal changes that affect drug transporters may influence the pharmacokinetics of the drugs. However, more systematic studies are required to better define the timing of pharmacologically important drug transporter regulation and determine tissue- and sex-dependent differences. Finally, the transfer of knowledge based on the results and conclusions obtained primarily from animal models will require careful validation before it is applied to humans.
溶质载体(SLC)和ATP结合盒(ABC)转运蛋白在肠道、肝脏和肾脏中表达,它们决定了药物的吸收、分布和排泄。此外,大多数分子和细胞过程呈现出由生物钟控制的昼夜节律,这导致许多药物的药代动力学和药效学出现昼夜变化,并影响其治疗效果和毒性。
本综述概述了目前关于药物转运蛋白昼夜节律及其昼夜控制分子机制的知识。讨论了将药物转运蛋白与昼夜振荡器耦合的证据,以及将昼夜节律信号传递给目标药物转运蛋白的可能候选者,特别是作为时钟基因输出的转录因子。
昼夜机制已被证明与各种药物转运蛋白的摄取和外排相互作用。证据支持这样一种概念,即影响药物转运蛋白的昼夜变化可能会影响药物的药代动力学。然而,需要更系统的研究来更好地确定药理学上重要的药物转运蛋白调节的时间,并确定组织和性别依赖性差异。最后,基于主要从动物模型获得的结果和结论的知识转移,在应用于人类之前需要仔细验证。